000919 金陵药业
已收盘 02-10 15:00:00
资讯
新帖
简况
金陵药业（000919）披露2026年度日常关联交易预计议案获临时股东大会通过，2月5日股价上涨0.77%
证券之星 · 02-05
金陵药业（000919）披露2026年度日常关联交易预计议案获临时股东大会通过，2月5日股价上涨0.77%
金陵药业(000919)1月30日股东户数3.35万户，较上期减少1.98%
证券之星 · 02-03
金陵药业(000919)1月30日股东户数3.35万户，较上期减少1.98%
金陵药业：截至2026年1月30日，公司股东人数为33,513
证券之星 · 02-02
金陵药业：截至2026年1月30日，公司股东人数为33,513
金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，1月29日股价上涨0.13%
证券之星 · 01-29
金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，1月29日股价上涨0.13%
股市必读：金陵药业(000919)股东户数3.42万户，较上期减少4.54%
证券之星 · 01-23
股市必读：金陵药业(000919)股东户数3.42万户，较上期减少4.54%
业绩连降、核心项目延期，金陵药业如何走出业绩低谷？
新京报 · 01-22
业绩连降、核心项目延期，金陵药业如何走出业绩低谷？
金陵药业（000919）披露召开2026年第一次临时股东会通知，1月21日股价上涨1.14%
证券之星 · 01-21
金陵药业（000919）披露召开2026年第一次临时股东会通知，1月21日股价上涨1.14%
金陵药业：截至2026年1月9日股东人数为35,817
证券之星 · 01-13
金陵药业：截至2026年1月9日股东人数为35,817
金陵药业：截至2025年12月31日股东人数为36,305
证券之星 · 01-06
金陵药业：截至2025年12月31日股东人数为36,305
金陵药业子公司使用闲置募集资金进行现金管理进展公告
中金财经 · 2025-12-30
金陵药业子公司使用闲置募集资金进行现金管理进展公告
金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，12月29日股价下跌1.55%
证券之星 · 2025-12-29
金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，12月29日股价下跌1.55%
金陵药业：截至2025年12月19日股东人数为37,395
证券之星 · 2025-12-22
金陵药业：截至2025年12月19日股东人数为37,395
金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%
证券之星 · 2025-12-18
金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%
金陵药业：截至2025年12月10日股东人数为32,789
证券之星 · 2025-12-12
金陵药业：截至2025年12月10日股东人数为32,789
金陵药业：截至2025年11月28日股东人数为32,882
证券之星 · 2025-12-01
金陵药业：截至2025年11月28日股东人数为32,882
金陵药业将清算注销全资子公司邦健天峰
中金财经 · 2025-11-29
金陵药业将清算注销全资子公司邦健天峰
金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目
证券之星 · 2025-11-28
金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目
金陵药业：公司将依法履行信息披露义务
证券日报 · 2025-11-26
金陵药业：公司将依法履行信息披露义务
金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%
证券之星 · 2025-11-21
金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%
金陵药业：截至11月10日股东户数为33417户
证券日报网 · 2025-11-17
金陵药业：截至11月10日股东户数为33417户
加载更多
公司概况
公司名称：
金陵药业股份有限公司
所属行业：
医药制造业
上市日期：
1999-11-18
主营业务：
金陵药业股份有限公司的主营业务是药品、医疗器械制造和医康养护服务。公司的主要产品是脉络宁注射液/口服液、琥珀酸亚铁片、香菇多糖注射液、吸收性明胶海绵等。“桂冠”商标为中国驰名商标，“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品，“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。
发行价格：
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":7.77,"timestamp":1770707004000,"preClose":7.74,"halted":0,"volume":10715301,"delay":0,"changeRate":0.0039,"floatShares":622000000,"shares":622000000,"eps":0.0603,"marketStatus":"已收盘","change":0.03,"latestTime":"02-10 15:00:00","open":7.74,"high":7.85,"low":7.68,"amount":83283100,"amplitude":0.022,"askPrice":7.77,"askSize":401,"bidPrice":7.76,"bidSize":373,"shortable":0,"etf":0,"ttmEps":0.0603,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"adjPreClose":7.74,"symbolType":"stock","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":8.51,"lowLimit":6.97,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.27,"roa":"--","peRate":128.855721,"roe":"1.8%","epsLYR":0.0682,"committee":-0.509552,"marketValue":4832000000,"turnoverRate":0.0172,"status":0,"floatMarketCap":4831000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2609011403","title":"金陵药业（000919）披露2026年度日常关联交易预计议案获临时股东大会通过，2月5日股价上涨0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609011403","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609011403?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:48","pubTimestamp":1770302899,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，金陵药业报收于7.83元，较前一交易日上涨0.77%，最新总市值为48.7亿元。近日，金陵药业股份有限公司发布《2026年第一次临时股东会决议公告》。公告显示，公司于2026年2月5日召开2026年第一次临时股东会，会议采用现场与网络投票结合方式，审议通过了《关于公司2026年度日常关联交易预计情况的议案》。出席会议股东共205人，代表股份37,147,263股，占公司有表决权股份总数的5.9730%。议案获得同意票34,922,902股，反对2,059,361股，弃权165,000股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"gpt_icon":0},{"id":"2608821574","title":"金陵药业(000919)1月30日股东户数3.35万户，较上期减少1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608821574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608821574?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:37","pubTimestamp":1770111458,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年1月30日公司股东户数为3.35万户，较1月20日减少677.0户，减幅为1.98%。在化学制药行业个股中，金陵药业股东户数低于行业平均水平，截至1月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月20日至2026年1月30日，金陵药业区间跌幅为3.43%，在此期间股东户数减少677.0户，减幅为1.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300030100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","000919","BK0096"],"gpt_icon":0},{"id":"2608773858","title":"金陵药业：截至2026年1月30日，公司股东人数为33,513","url":"https://stock-news.laohu8.com/highlight/detail?id=2608773858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608773858?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:04","pubTimestamp":1770015865,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截至1月30日的股东人数是多少？金陵药业回复：投资者，您好！截至2026年1月30日，公司股东人数为33,513，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200015109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0239","BK0096"],"gpt_icon":0},{"id":"2607360430","title":"金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，1月29日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607360430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607360430?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:06","pubTimestamp":1769699180,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，金陵药业报收于7.61元，较前一交易日上涨0.13%，最新总市值为47.33亿元。公告显示，池州东升药业有限公司和合肥金陵天颐智慧养老服务有限公司此前购买的多笔大额存单产品已于2026年1月28日到期赎回，合计赎回本金并获得相应收益。同时，相关募集资金现金管理专用结算账户已由银行自动注销。截至公告日，公司使用闲置募集资金进行现金管理尚未到期的金额为49,600万元，未超出股东大会批准的额度范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"gpt_icon":0},{"id":"2605411633","title":"股市必读：金陵药业(000919)股东户数3.42万户，较上期减少4.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605411633?lang=zh_cn&edition=full","pubTime":"2026-01-23 02:47","pubTimestamp":1769107630,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，金陵药业报收于7.97元，上涨0.0%，换手率1.88%，成交量11.71万手，成交额9295.47万元。来自股本股东变化：截至2026年1月20日，公司股东户数环比减少4.54%，户均持股量上升至1.82万股，表明筹码集中度有所提升。股本股东变化股东户数变动近日金陵药业披露，截至2026年1月20日公司股东户数为3.42万户，较1月9日减少1627.0户，减幅为4.54%。截至2026年1月20日，公司股东人数为34,190，感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300001485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0239","BK0028"],"gpt_icon":0},{"id":"2605666224","title":"业绩连降、核心项目延期，金陵药业如何走出业绩低谷？","url":"https://stock-news.laohu8.com/highlight/detail?id=2605666224","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605666224?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:27","pubTimestamp":1769070420,"startTime":"0","endTime":"0","summary":"在业绩持续承压、转型布局遇阻的双重考验下，金陵药业该如何走出业绩低谷？募投滞后、资金闲置此次延期的核心原料药项目，是金陵药业2024年定增募资的重点投向之一。截至2025年9月底，金陵药业募集资金余额达7.29亿元，其中6.8亿元用于现金管理，闲置比例超过93%。不过，近年来，金陵药业核心业务增长乏力，业绩持续下滑。为扭转颓势，金陵药业已在积极寻求突围路径。2025年上半年，金陵药业研发投入4534.16万元，同比增长20.51%。","market":"sh","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl882026122162192878601.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl882026122162192878601.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1769070421168010.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1769070421168010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0096","BK0239","BK0028","000919"],"gpt_icon":0},{"id":"2605170685","title":"金陵药业（000919）披露召开2026年第一次临时股东会通知，1月21日股价上涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605170685","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605170685?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:37","pubTimestamp":1768988220,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，金陵药业报收于7.97元，较前一交易日上涨1.14%，最新总市值为49.57亿元。该股当日开盘7.82元，最高8.1元，最低7.73元，成交额达1.42亿元，换手率为2.87%。公司近日发布公告称，将于2026年2月5日召开2026年第一次临时股东会，会议由董事会召集，现场会议时间为当日14:30，网络投票时间为同日9:15至15:00。股权登记日为2026年1月30日。股东可选择现场或网络投票方式参会，中小股东表决情况将单独计票。登记时间截至2026年2月4日17:00。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100029322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"gpt_icon":0},{"id":"2603571843","title":"金陵药业：截至2026年1月9日股东人数为35,817","url":"https://stock-news.laohu8.com/highlight/detail?id=2603571843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603571843?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:35","pubTimestamp":1768275303,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至1月10日公司的股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2026年1月9日，公司股东人数为35,817，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300016060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"gpt_icon":0},{"id":"2601986123","title":"金陵药业：截至2025年12月31日股东人数为36,305","url":"https://stock-news.laohu8.com/highlight/detail?id=2601986123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601986123?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:21","pubTimestamp":1767684076,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问截止到2025年12月31日，贵公司股东户数是多少？谢谢啦！！！金陵药业回复：投资者，您好！截至2025年12月31日，公司股东人数为36,305，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600020059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0028","BK0239"],"gpt_icon":0},{"id":"2595308715","title":"金陵药业子公司使用闲置募集资金进行现金管理进展公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2595308715","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595308715?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:18","pubTimestamp":1767107899,"startTime":"0","endTime":"0","summary":"根据公告，子公司合肥金陵天颐智慧养老服务有限公司此前购买的南京银行结构性存款产品已按期赎回，共计收回本金15,600万元及收益270.97万元。同时，该公司使用闲置募集资金新购买了南京银行的两款保本浮动收益型结构性存款产品，金额分别为11,000万元和4,600万元，期限均为360天。截至公告日，公司及子公司使用闲置募集资金进行现金管理尚未到期的余额为68,000万元，未超出股东大会批准的70,000万元额度范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251230/31905042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","000919","BK0096","BK0239"],"gpt_icon":0},{"id":"2595673521","title":"金陵药业（000919）披露使用闲置募集资金进行现金管理的进展公告，12月29日股价下跌1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673521?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:24","pubTimestamp":1767018261,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，金陵药业报收于7.6元，较前一交易日下跌1.55%，最新总市值为47.27亿元。近日，金陵药业股份有限公司发布公告，披露其子公司合肥金陵天颐智慧养老服务有限公司使用闲置募集资金进行现金管理的最新进展。公告显示，此前到期的两笔结构性存款已成功赎回，合计收回本金15,600万元，获得实际收益270.97万元。截至公告日，尚未到期的募集资金现金管理余额为68,000万元，未超出股东大会批准额度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900037919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"gpt_icon":0},{"id":"2593910065","title":"金陵药业：截至2025年12月19日股东人数为37,395","url":"https://stock-news.laohu8.com/highlight/detail?id=2593910065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593910065?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:25","pubTimestamp":1766391911,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止到12.20日的股东人数是多少?谢谢！金陵药业回复：投资者，您好！截至2025年12月19日，公司股东人数为37,395，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200016721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"gpt_icon":0},{"id":"2592904786","title":"金陵药业（000919）披露南京梅山医院投资改扩建项目获股东会通过，12月18日股价上涨6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904786","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904786?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:23","pubTimestamp":1766067818,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，金陵药业报收于7.37元，较前一交易日上涨6.35%，最新总市值为45.84亿元。该股当日开盘6.91元，最高7.43元，最低6.91元，成交额达2.04亿元，换手率为4.54%。公司近日发布公告称，于2025年12月18日召开第四次临时股东会，审议通过关于南京梅山医院投资改扩建项目的议案。会议采用现场与网络投票结合方式，出席股东211人，代表股份占公司有表决权股份总数的43.9370%。议案获总同意票占比99.4905%，中小股东同意票占比89.9585%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0028","BK0239"],"gpt_icon":0},{"id":"2590652172","title":"金陵药业：截至2025年12月10日股东人数为32,789","url":"https://stock-news.laohu8.com/highlight/detail?id=2590652172","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590652172?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:36","pubTimestamp":1765510596,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年12月10日A股股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2025年12月10日，公司股东人数为32,789，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200013682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","000919","BK0028"],"gpt_icon":0},{"id":"2588741021","title":"金陵药业：截至2025年11月28日股东人数为32,882","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588741021?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:12","pubTimestamp":1764573125,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年11月28日A股股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2025年11月28日，公司股东人数为32,882，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0239","BK0096"],"gpt_icon":0},{"id":"2587680750","title":"金陵药业将清算注销全资子公司邦健天峰","url":"https://stock-news.laohu8.com/highlight/detail?id=2587680750","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587680750?lang=zh_cn&edition=full","pubTime":"2025-11-29 17:31","pubTimestamp":1764408662,"startTime":"0","endTime":"0","summary":"中访网数据 金陵药业股份有限公司于2025年11月28日召开第九届董事会第二十二次会议，审议通过了关于清算注销其全资子公司湖州邦健天峰药业有限公司的议案。根据审计报告，截至2024年12月31日，该公司总资产为314.86万元，净资产为307.57万元，2024年度营业收入为44.54万元，净利润为0.39万元。公司表示，此次清算不会对公司当期及未来财务状况和经营成果产生重大影响，清算完成后邦健天峰将不再纳入公司合并报表范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251129/31833743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000919","BK0239","BK0028","BK0096"],"gpt_icon":0},{"id":"2586781061","title":"金陵药业最新公告：拟投资8.93亿元实施医院改扩建项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781061","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586781061?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:00","pubTimestamp":1764331213,"startTime":"0","endTime":"0","summary":"金陵药业(000919.SZ)公告称，控股子公司南京梅山医院为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与服务能力，拟投资8.93亿元实施医院改扩建项目。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800033934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0028","BK0096"],"gpt_icon":0},{"id":"2586252023","title":"金陵药业：公司将依法履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2586252023","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586252023?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:40","pubTimestamp":1764160800,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-26/doc-infytuqz1658552.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-26/doc-infytuqz1658552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000919","BK0096","BK0028","BK0239"],"gpt_icon":0},{"id":"2585111147","title":"金陵药业(000919)11月20日股东户数3.29万户，较上期减少1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585111147","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585111147?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:14","pubTimestamp":1763720045,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2025年11月20日公司股东户数为3.29万户，较11月10日减少527.0户，减幅为1.58%。在化学制药行业个股中，金陵药业股东户数低于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年11月10日至2025年11月20日，金陵药业区间跌幅为2.04%，在此期间股东户数减少527.0户，减幅为1.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100028554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","000919","BK0028"],"gpt_icon":0},{"id":"2584475776","title":"金陵药业：截至11月10日股东户数为33417户","url":"https://stock-news.laohu8.com/highlight/detail?id=2584475776","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584475776?lang=zh_cn&edition=full","pubTime":"2025-11-17 18:38","pubTimestamp":1763375880,"startTime":"0","endTime":"0","summary":"证券日报网讯金陵药业11月17日在互动平台回答投资者提问时表示，截至2025年11月10日，公司股东人数为33417户。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxtkpy4786902.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-17/doc-infxtkpy4786902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","000919","BK0096","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770731005685,"stockEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.014},{"period":"3month","weight":0.0431},{"period":"6month","weight":0.0676},{"period":"1year","weight":0.1899},{"period":"ytd","weight":-0.0264}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33513人(较上一季度减少1.98%)","perCapita":"18553股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品、医疗器械制造和医康养护服务。公司的主要产品是脉络宁注射液/口服液、琥珀酸亚铁片、香菇多糖注射液、吸收性明胶海绵等。“桂冠”商标为中国驰名商标，“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品，“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}